Due to the high cost of medication in the US, getting live-saving insulin has not just become unattainable but in some cases even fatal.

Despite promises from politicians and pharmaceutical companies, insulin prices seem to remain significantly higher than many other first world countries such as Canada and Britain.

Many have turned the insulin debate into a political one comparing the Trump vs Biden administration on handling insulin prices.

Regardless of how you lean politically, it is estimated that 92% of American’s agree that insulin prices need to be addressed.

In almost record time, many companies have been able to develop a vaccine for COVID that will be readily available in 2021 to save lives from a virus that has already claimed millions globally.

Unfortunately, life saving insulin is out of reach for many American’s who are struggling to make ends meet during a global pandemic/recession.

Insulin rationing has already claimed 4 lives in 2020 in addition to others who have been hospitalized for diabetic ketoacidosis or falling into a diabetic coma.

Right Care Alliance has several tragic examples of American’s who have died due to insulin rationing.

Meaghan Carter, age 47, Ohio (December 25, 2018) — Meaghan Carter had type 1 diabetes for 18 years. When she lost her job and insurance, she struggled to afford her insulin which cost more than $800 a month. She resorted to buying NPH insulin (intermediate-acting insulin) from Walmart, which is cheaper but much more unpredictable than the insulin she normally used. On Christmas Day, 2018, Meaghan died of diabetic ketoacidosis, one day before she would have received a paycheck that could have saved her life.

Due to high costs, currently 1 in 4 American’s are using less insulin than prescribed. This number can be staggering when you consider that over 1/10 Americans have diabetes.

One would think that this rationing would come from families who are on the brink of poverty, but are in fact many living in middle-class backgrounds and have health insurance.

No American should subject themselves to rationing their insulin as part of their financial planning, sharing insulin with others or worse, going completely without their life-saving medication.

The cost of producing insulin in the US on average is $4 per vial but may retail for $300.